Aileron Therapeutics

-$0.0219 (-5.23%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ALRN and other ETFs, options, and stocks.

About ALRN

Aileron Therapeutics, Inc. operates as a clinical stage biopharmaceutical company engaged in the development and commercialization of a novel class of therapeutics for the treatment of cancer and other diseases. It focuses on its lead product candidate, ALRN-6924, which is a cell-permeating peptide that disrupts the interaction of p53 suppressors MDM2 and MDMX with tumor suppressor p53 to reactivate tumor suppression in non-mutant, or wild-type, p53 cancers.

CEO
Manuel C. Alves Aivado
Employees
9
Headquarters
Boston, Massachusetts
Founded
2001

ALRN Key Statistics

Market cap
36.05M
Price-Earnings ratio
—
Dividend yield
—
Average volume
201.21K
High today
$0.45
Low today
$0.4062
Open price
$0.4062
Volume
348.97K
52 Week high
$1.40
52 Week low
$0.32

ALRN Earnings

-$0.13
-$0.09
-$0.04
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 10, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure